The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
Abstract
OBJECTIVE: To report late reactivation and progression of retinopathy of prematurity (ROP) after intravitreal bevacizumab monotherapy. METHODS: Retrospective review of 9 patients (17 eyes) with recurrence of ROP after initial treatment with intravitreal bevacizumab monotherapy. Data collected included (1) location and stage of ROP activity, (2) number and timing of treatments, and (3) structural outcomes. RESULTS: Mean age at treatment-requiring recurrence was 49.3 weeks (SD, 9.1 weeks; minimum, 37 weeks; maximum, 69 weeks) postmenstrual age (PMA). The mean time between initial treatment and treatment-requiring recurrence was 14.4 weeks, with a minimum of 4 and maximum of 35 weeks. Fives eyes progressed to retinal detachment (4 eyes stage 5, 1 eye stage 4a). Age at retinal detachment ranged from 49 to 69 weeks PMA with a median of 55 weeks PMA and mean of 58.4 weeks PMA. No eye that received laser treatment for recurrence progressed to retinal detachment. CONCLUSIONS: Although intravitreal bevacizumab treatment is effective in inducing regression of ROP, the effect may be transient. Recurrence can occur later in the course than with conventional laser therapy. Late retinal detachment can occur despite early regression. Longterm favorable structural outcome may require extended observation and retreatment. Laser may be a useful treatment for recurrences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Retinopathy of Prematurity Revisited
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.7.991 · Cited by 2,932
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Mintz-Hittner, H. A., Kennedy, K. A., & Chuang, A. Z. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007374 · Cited by 1,455
Gole, G. A., Ells, A. L., Katz, X., Holmström, G. E., Fielder, A. R., Capone, A., Flynn, J. T., Good, W., Holmes, J. M., McNamara, J. A., et al. (2005) · Archives of Ophthalmology · Cited by 1,386
Self-citationAn international classification of retinopathy of prematurity
(1985) · International Ophthalmology · doi:10.1007/bf00136454 · Cited by 1,005
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1769 · Cited by 1,001
Chen, J., & Smith, L. E. H. (2007) · Angiogenesis · doi:10.1007/s10456-007-9066-0 · Cited by 602
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: Preliminary Results
Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) · Pediatrics · doi:10.1542/peds.81.5.697 · Cited by 503
(2016) · Juntendo Medical Journal · doi:10.14789/jmj.62.54 · Cited by 295
Pathogenesis of retinopathy of prematurity
Smith, L. (2002) · Acta Paediatrica · doi:10.1111/j.1651-2227.2002.tb00157.x · Cited by 110
Cited by
Screening Examination of Premature Infants for Retinopathy of Prematurity
Fierson, W. M., AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology, AMERICAN ACADEMY OF OPHTHALMOLOGY, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS, Chiang, M. F., Good, W., Phelps, D., Reynolds, J., Robbins, S. L., et al. (2018) · Pediatrics · doi:10.1542/peds.2018-3061 · Cited by 1,460
Ghasemi Falavarjani, K., & Nguyen, Q. D. (2013) · Eye · doi:10.1038/eye.2013.107 · Cited by 982
Mechanisms and Management of Retinopathy of Prematurity
Hartnett, M. E., & Penn, J. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1208129 · Cited by 637
Metadata
- Authors
- Hu, J., Blair, M. P., Shapiro, M. J., Lichtenstein, S. J., Galasso, J. M., & Kapur, R.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2012-08-01
- Volume
- 130
- Issue
- 8
- Pages
- 1000
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2078546898
- Cited by
- 304
- References
- 9
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reactivation of Retinopathy of Prematurity After Bevacizumab Injection. https://app.cochat.ai/papers/10.1001/archophthalmol.2012.592
- The paper
- Hu, J., Blair, M. P., Shapiro, M. J., Lichtenstein, S. J., Galasso, J. M., & Kapur, R. (2012). Reactivation of Retinopathy of Prematurity After Bevacizumab Injection. Archives of Ophthalmology. https://doi.org/10.1001/archophthalmol.2012.592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.